Cleandro Pires de Albuquerque

High levels of immunosuppression are related to unfavourable outcomes in hospitalised patients with rheumatic diseases and COVID-19: first results of ReumaCoV Brasil registry

Cláudia Diniz Lopes Marques, Adriana María Kakehasi, Marcelo Medeiros Pinheiro et al. · RMD Open · 2021 · 74 citations · Full text

2017 recommendations of the Brazilian Society of Rheumatology for the pharmacological treatment of rheumatoid arthritis

Lícia Maria Henrique da Mota, Adriana María Kakehasi, Ana Paula Monteiro Gomides et al. · Advances in Rheumatology · 2018 · 45 citations · Full text

The REAL study: a nationwide prospective study of rheumatoid arthritis in Brazil

Geraldo da Rocha Castelar Pinheiro, Ana Beatriz Vargas‐Santos, Cleandro Pires de Albuquerque et al. · Advances in Rheumatology · 2018 · 38 citations · Full text

High Levels of Polypharmacy in Rheumatoid Arthritis—A Challenge Not Covered by Current Management Recommendations: Data From a Large Real-Life Study

Ana Paula Monteiro Gomides, Cleandro Pires de Albuquerque, Ana Beatriz Vargas‐Santos et al. · Journal of Pharmacy Practice · 2019 · 37 citations

Discordance between the patient’s and physician’s global assessment in rheumatoid arthritis: Data from the REAL study—Brazil

Maria Fernanda Brandão de Resende Guimarães, Maria Raquel da Costa Pinto, Gustavo Gomes Resende et al. · PLoS ONE · 2020 · 36 citations · Full text